ATE208774T1 - Arylsulfonylimidazolon-derivate als antitumormittel - Google Patents

Arylsulfonylimidazolon-derivate als antitumormittel

Info

Publication number
ATE208774T1
ATE208774T1 AT97936869T AT97936869T ATE208774T1 AT E208774 T1 ATE208774 T1 AT E208774T1 AT 97936869 T AT97936869 T AT 97936869T AT 97936869 T AT97936869 T AT 97936869T AT E208774 T1 ATE208774 T1 AT E208774T1
Authority
AT
Austria
Prior art keywords
tumor agents
arylsulfonylimidazolone
derivatives
arylsulfonylimidazolone derivatives
uns
Prior art date
Application number
AT97936869T
Other languages
English (en)
Inventor
Sung June Yoon
Yong Ho Chung
Moon Sun Lee
Dong Rack Choi
Jung A Lee
Hee Soon Lee
Hae Ran Yun
Dug Keun Lee
Eun Yi Moon
Hyun Sook Hwang
Chung Ha Choi
Sang Hun Jung
Original Assignee
Dong Wha Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960034920A external-priority patent/KR19980015550A/ko
Priority claimed from KR1019960051939A external-priority patent/KR100438482B1/ko
Priority claimed from KR1019960053450A external-priority patent/KR100435085B1/ko
Priority claimed from KR1019970019365A external-priority patent/KR100437670B1/ko
Application filed by Dong Wha Pharm Ind Co Ltd filed Critical Dong Wha Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE208774T1 publication Critical patent/ATE208774T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)
AT97936869T 1996-08-22 1997-08-20 Arylsulfonylimidazolon-derivate als antitumormittel ATE208774T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1019960034920A KR19980015550A (ko) 1996-08-22 1996-08-22 신규한 벤조일로 치환된 인돌린설포닐우레아 유도체
KR1019960051939A KR100438482B1 (ko) 1996-11-05 1996-11-05 신규한디아릴설포닐이미다졸론유도체
KR1019960053450A KR100435085B1 (ko) 1996-11-12 1996-11-12 신규설포닐이미다졸론유도체
KR1019970019365A KR100437670B1 (ko) 1997-05-19 1997-05-19 (s)-이성체형태의인돌린설포닐우레아유도체
PCT/KR1997/000154 WO1998007719A1 (en) 1996-08-22 1997-08-20 Arylsulfonylimidazolone derivatives as an antitumor agent

Publications (1)

Publication Number Publication Date
ATE208774T1 true ATE208774T1 (de) 2001-11-15

Family

ID=27483149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97936869T ATE208774T1 (de) 1996-08-22 1997-08-20 Arylsulfonylimidazolon-derivate als antitumormittel

Country Status (9)

Country Link
US (2) US5929103A (de)
EP (1) EP1021437B1 (de)
JP (1) JP3226100B2 (de)
CN (1) CN1079096C (de)
AT (1) ATE208774T1 (de)
AU (1) AU709107B2 (de)
CA (1) CA2263353C (de)
DE (1) DE69708340T2 (de)
WO (1) WO1998007719A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (de) 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
KR20030082292A (ko) * 2002-04-17 2003-10-22 주식회사 엘지생명과학 신규한 인돌린설포닐우레아 유도체 및 그를 함유하는항암제 조성물
KR20030082294A (ko) * 2002-04-17 2003-10-22 주식회사 엘지생명과학 신규한 아릴설포닐우레아 유도체, 그의 제조방법 및 그를함유하는 항암제 조성물
US7358269B2 (en) * 2002-05-21 2008-04-15 Allergan, Inc. 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
US7323485B2 (en) 2002-05-21 2008-01-29 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7091232B2 (en) * 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
GB0421525D0 (en) * 2004-09-28 2004-10-27 Novartis Ag Inhibitors of protein kineses
TWI329102B (en) * 2006-08-15 2010-08-21 Nat Health Research Institutes Thiourea compounds and method for inhibiting hepatitis c virus infection
US7985763B2 (en) * 2007-04-10 2011-07-26 National Health Research Institutes Hepatitis C virus inhibitors
TW200848016A (en) * 2007-06-08 2008-12-16 Nat Health Research Institutes Thiourea compound and composition of treating hepatitis C virus infection
KR100965247B1 (ko) * 2008-02-13 2010-06-22 일동제약주식회사 신규한 아릴설포닐이미다졸론 유도체 화합물 및 그화합물을 함유한 항암제 조성물
US8198284B2 (en) * 2008-04-30 2012-06-12 National Health Research Institutes Treatment of neurodegenerative disorders with thiourea compounds
KR101458494B1 (ko) * 2010-07-08 2014-11-07 충남대학교산학협력단 신규한 아릴설포닐이미다졸론 유도체 및 이를 함유하는 항암제 조성물
PL231063B1 (pl) 2013-04-10 2019-01-31 Oncoarendi Therapeutics Spolka Z Ograniczona Odpowiedzialnoscia Pochodne 1-(podstawionej sulfonylo)-2-aminoimidazoliny jako środki przeciwnowotworowe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
US5110830A (en) * 1984-06-27 1992-05-05 Eli Lilly And Company Benzenesulfonamides treatment of tumors susceptible to
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US4677131A (en) * 1985-11-01 1987-06-30 Merck & Co., Inc. Cyclic ureas as dermal penetration enhancers
JP2764262B2 (ja) * 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
FI902028A7 (fi) * 1988-08-24 1990-04-23 Mochida Pharm Co Ltd Hydantoiinijohdannaisia
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
CN1228088A (zh) 1999-09-08
US5932742A (en) 1999-08-03
EP1021437A1 (de) 2000-07-26
DE69708340T2 (de) 2002-05-16
DE69708340D1 (de) 2001-12-20
WO1998007719A1 (en) 1998-02-26
CN1079096C (zh) 2002-02-13
CA2263353C (en) 2002-04-23
JP2000505096A (ja) 2000-04-25
CA2263353A1 (en) 1998-02-26
JP3226100B2 (ja) 2001-11-05
AU3952997A (en) 1998-03-06
US5929103A (en) 1999-07-27
AU709107B2 (en) 1999-08-19
EP1021437B1 (de) 2001-11-14

Similar Documents

Publication Publication Date Title
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
ATE208774T1 (de) Arylsulfonylimidazolon-derivate als antitumormittel
NO20014128L (no) Camptothecinderivater som har antitumoraktivitet
ATE225341T1 (de) In 6-position durch thio substituierte paclitaxele
WO2005007103A3 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
TR200001452T2 (tr) Bifenilamidin türevleri.
MXPA05005198A (es) Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
GB0218816D0 (en) Antitumoral analogs of lamellarins
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
ZA200408029B (en) Novel 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors.
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
CA2188931A1 (en) Agent for treating cor pulmonale
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
SE9803107D0 (sv) Novel Compunds
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
CO5021190A1 (es) Agentes terapeuticos
FI950101A0 (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina
NO20011578L (no) Anvendelse av acylkarnitiner som antitumormidler
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
NO950061D0 (no) 4-oksa-1-azabisyklo [3,2,0Å heptan-7-on-derivater som antitumormidler
CA2493704A1 (en) Platinum complexes containing chemically modified bile acids, having antitumor activity
DK1177185T3 (da) 4,5,6,7-tetrahydroindazolderivater som antitumormidler